Brinker Capital Investments’s Thermo Fisher Scientific TMO Stock Holding History

Brinker Capital Investments’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.12M	Sell	16,511 -2,324	-12%	-$1.26M	0.07%	248
2025 Q4	$10.9M	Sell	18,835 -267	-1%	-$151K	0.08%	227
2025 Q3	$9.26M	Sell	19,102 -7,727	-29%	-$3.6M	0.07%	253
2025 Q2	$10.9M	Sell	26,829 -15,188	-36%	-$6.35M	0.09%	200
2025 Q1	$20.9M	Sell	42,017 -922	-2%	-$499K	0.2%	94
2024 Q4	$22.3M	Sell	42,939 -85	-0.2%	-$46.7K	0.22%	82
2024 Q3	$26.6M	Sell	43,024 -1,476	-3%	-$874K	0.27%	66
2024 Q2	$24.6M	Sell	44,500 -2,397	-5%	-$1.37M	0.26%	68
2024 Q1	$27.3M	Buy	46,897 +3,362	+8%	+$1.89M	0.29%	60
2023 Q4	$23.6M	Sell	43,535 -10,689	-20%	-$5.17M	0.27%	71
2023 Q3	$27.4M	Sell	54,224 -2,636	-5%	-$1.4M	0.33%	53
2023 Q2	$25.3M	Buy	56,860 +344	+0.6%	+$186K	0.27%	63
2023 Q1	$32.6M	Buy	56,516 +6,423	+13%	+$3.62M	0.4%	38
2022 Q4	$27.6M	Sell	50,093 -2,417	-5%	-$1.28M	0.55%	27
2022 Q3	$26.6M	Sell	52,510 -1,537	-3%	-$860K	0.55%	30
2022 Q2	$29.4M	Sell	54,047 -6,128	-10%	-$3.37M	0.56%	32
2022 Q1	$35.5M	Sell	60,175 -1,340	-2%	-$770K	0.55%	36
2021 Q4	$41M	Sell	61,515 -2,403	-4%	-$1.5M	0.6%	27
2021 Q3	$32.4M	Buy	63,918 +520	+0.8%	+$285K	0.51%	34
2021 Q2	$32M	Buy	63,398 +8,382	+15%	+$3.95M	0.42%	45
2021 Q1	$25.1M	Buy	55,016 +27,856	+103%	+$13.3M	0.38%	64
2020 Q4	$12.7M	Sell	27,160 -19,863	-42%	-$9.31M	0.2%	102
2020 Q3	$20.8M	Buy	47,023 +44,179	+1,553%	+$18.3M	0.36%	58
2020 Q2	$1.03M	Buy	+2,844	New	+$953K	0.04%	211
2020 Q1	–	Sell	-409	Closed	-$133K	–	710
2019 Q4	$133K	Buy	409 +2	+0.5%	+$606	﹤0.01%	355
2019 Q3	$119K	Buy	407 +57	+16%	+$16.3K	﹤0.01%	363
2019 Q2	$103K	Hold	350	–	–	﹤0.01%	476
2019 Q1	$96K	Sell	350 -32	-8%	-$7.96K	﹤0.01%	393
2018 Q4	$85K	Hold	382	–	–	﹤0.01%	356
2018 Q3	$93K	Sell	382 -22	-5%	-$5.06K	﹤0.01%	327
2018 Q2	$84K	Buy	404 +30	+8%	+$6.37K	﹤0.01%	338
2018 Q1	$77K	Sell	374 -35	-9%	-$7.35K	﹤0.01%	329
2017 Q4	$78K	Hold	409	–	–	﹤0.01%	336
2017 Q3	$77K	Hold	409	–	–	﹤0.01%	325
2017 Q2	$71K	Buy	409 +3	+0.7%	+$504	﹤0.01%	313
2017 Q1	$62K	Hold	406	–	–	﹤0.01%	304
2016 Q4	$57K	Sell	406 -3,112	-88%	-$459K	﹤0.01%	299
2016 Q3	$560K	Sell	3,518 -47	-1%	-$7.24K	0.02%	206
2016 Q2	$527K	Sell	3,565 -345	-9%	-$50.9K	0.02%	212
2016 Q1	$554K	Buy	3,910 +269	+7%	+$36K	0.02%	207
2015 Q4	$517K	Buy	3,641 +636	+21%	+$84.8K	0.02%	226
2015 Q3	$367K	Sell	3,005 -241	-7%	-$31.4K	0.02%	240
2015 Q2	$421K	Sell	3,246 -252	-7%	-$32.9K	0.02%	229
2015 Q1	$470K	Buy	3,498 +85	+2%	+$11K	0.02%	220
2014 Q4	$428K	Sell	3,413 -65	-2%	-$7.9K	0.02%	226
2014 Q3	$423K	Sell	3,478 -376	-10%	-$45.7K	0.02%	216
2014 Q2	$455K	Buy	+3,854	New	+$454K	0.02%	227
2013 Q3	–	Sell	-3,124	Closed	-$264K	–	396
2013 Q2	$264K	Buy	+3,124	New	+$260K	0.01%	244

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brinker Capital Investments's TMO Position: Q1 2026 in Review

Brinker Capital Investments reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, selling an estimated $1.26M and leaving 16,511 shares worth $8.12M. The position accounts for 0.07% of the portfolio, ranked #248.

Brinker Capital Investments first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. The position peaked at $41M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Brinker Capital Investments held 16,511 shares of Thermo Fisher Scientific worth $8.12M as of Q1 2026.
Brinker Capital Investments sold 2,324 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.26M.
Thermo Fisher Scientific made up 0.07% of Brinker Capital Investments's portfolio in Q1 2026, its #248 holding.
Brinker Capital Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
Brinker Capital Investments's Thermo Fisher Scientific position peaked at $41M in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.